UV GERMI Societe Anonyme

UV GERMI Societe Anonyme

EEURONEXT:ALUVI
2.34
EUR
0.00
(0.00%)
8.65MMarket Cap
Apr 23Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.45
1.85
1.92
1.85
2
2.4
2.59
2.47
2.31
2.53
2.68
2.83
- -
Basic EPS, GAAP
0.06
-0.04
-0.1
-0.07
-0.14
0.04
0.16
-0.34
0.02
0.09
0.22
0.04
- -
Free Cash Flow per Basic Share
-0.18
-0.12
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.71
0.85
0.74
2.52
2.38
2.42
2.58
2.3
2.84
2.87
3.11
4.13
3.11
Tangible Book Value per Share
0.66
0.75
0.6
2.39
2.25
2.28
2.34
2.01
2.66
2.55
2.74
3.64
2.74
Basic Weighted Avg Shares
2
2
2
3
3
3
3
3
3
3
3
2
3
Sales/Revenue/Turnover
3
4
4
5
5
6
7
6
7
8
9
7
- -
Operating Margin (%)
1.02
-4.58
-7.78
-5.39
-8.46
-1.32
1.46
-15.51
1.93
6.96
6.68
1.34
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
1
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
4.04
-2.31
-5.43
-3.92
-7.01
1.55
6.16
-13.76
0.92
3.61
8.34
1.49
- -
Working Capital
1
2
2
6
6
5
5
5
8
8
8
8
8
LT Debt
- -
1
1
1
1
1
1
1
1
- -
- -
- -
- -
Total Equity
2
2
2
7
6
6
7
6
9
9
10
10
10
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-5.45
-13.05
-4.54
-5.72
1.55
6.38
-13.87
0.9
3.23
7.48
1.02
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
11
9
9

Working Capital

EUR

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
9
10
9
Cash, Cash Equivalents & STI
3
4
5
Accounts Receivable, Net
2
2
1
Inventories
3
3
3
Total Current Liabilities
1
2
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
32.09%
10.15%
0.56%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
39.71%
-4.19%
-85.73%
Sales/Revenue/Turnover
5.38%
1.26%
-20.05%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
8
2024
- -
- -
9
2025
- -
- -
7

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.09
2024
- -
- -
0.22
2025
- -
- -
0.04

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
André Bordas
Full Time Employees
39
Sector
Producer manufacturing
Industry
Industrial machinery
Address
ZAC de la Nau Saint-Viance NA France 19240
IPO Date
Jul 21, 2017
Website
uvgermi.fr
Business
UV Germi SA designs, manufactures, and sells ultraviolet (UV) devices primarily for the treatment and depollution of air, water, and surfaces. Its product portfolio includes UV reactors and sterilizers targeting various applications such as drinking water, seawater, dechloramination, wastewater and industrial process water, private pools, legionella control, Germiserre systems, industrial clean water, and livestock farming industries. The company also provides comprehensive after-sales services including installation, online repairs, technical advice, diagnostics, spare parts, on-site intervention, and user training. Founded in 2009 and headquartered in Saint-Viance, France, UV Germi operates mainly within France where approximately 85% of net sales derive. A significant recent operational change includes the acquisition of a 24.38% stake by CEO Willy Fortunato from founding family members. The company emphasizes continuous R&D innovation to enhance the environmental efficacy and performance of its UV treatment technologies, which are entirely manufactured in France, and has positioned itself as a provider of environmentally sensitive solutions without chemical usage. UV Germi serves diverse markets including households, local authorities, and industry sectors with a strategic focus on purifying air, disinfecting water, and sanitizing surfaces across multiple industrial and environmental segments. Recent developments also include broadening offerings in wastewater recycling technologies suitable for irrigation and reinforcing its environmental impact goals through proprietary non-toxic UV platforms. The company is listed on Euronext Paris under ticker ALUVI.PA.